STANDEX INTERNATIONAL CORP/DE/
For the period ended Dec 31, 2025. Filed Feb 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2025 · Filed Feb 2, 2026
Contents
Item 1. Unaudited Condensed Consolidated Balance Sheets
| (In thousands, except share and per share data) | December 31, 2025 | June 30, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $96,998 | $104,542 |
| Accounts receivable, less allowance for credit losses of $4,051 and $3,985 at December 31, 2025 and June 30, 2025, respectively | 176,628 | 172,702 |
| Inventories | 131,196 | 129,994 |
| Contract assets | 62,874 | 59,228 |
| Prepaid expenses and other current assets | 23,038 | 14,413 |
| Total current assets | 490,734 | 480,879 |
| Property, plant, and equipment, net | 160,378 | 160,364 |
| Intangible assets, net | 212,052 | 225,757 |
| Goodwill | 594,080 | 610,338 |
| Deferred tax asset | 11,687 | 11,971 |
| Operating lease right-of-use asset | 47,835 | 47,998 |
| Other non-current assets | 37,735 | 29,573 |
| Total non-current assets | 1,063,767 | 1,086,001 |
| Total assets | $1,554,501 | $1,566,880 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $87,773 | $88,001 |
| Accrued liabilities | 69,403 | 63,204 |
| Income taxes payable | 13,633 | 15,770 |
| Total current liabilities | 170,809 | 166,975 |
| Long-term debt | 534,733 | 552,515 |
| Operating lease long-term liabilities | 37,997 | 40,057 |
| Accrued pension and other non-current liabilities | 66,215 | 67,743 |
| Total non-current liabilities | 638,945 | 660,315 |
| Contingencies (Note 15) | ||
| Redeemable noncontrolling interest | 44,511 | 27,913 |
| Stockholders' equity: | ||
| Common stock, par value $1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 12,047,561 and 11,992,116 shares outstanding at December 31, 2025 and June 30, 2025 | 41,976 | 41,976 |
| Additional paid-in capital | 140,476 | 136,082 |
| Retained earnings | 1,136,096 | 1,126,851 |
| Accumulated other comprehensive loss | (188,019) | (164,765) |
| Treasury shares: 15,936,717 and 15,992,162 shares at December 31, 2025 and June 30, 2025 | (430,293) | (428,467) |
| Total stockholders' equity | 700,236 | 711,677 |
| Total liabilities and stockholders' equity | $1,554,501 | $1,566,880 |
Unaudited Condensed Consolidated Statements of Operations
| Three Months Ended December 31, | Six Months Ended December 31, | |||
|---|---|---|---|---|
| (In thousands, except per share data) | 2025 | 2024 | 2025 | 2024 |
| Net sales | $221,320 | $189,814 | $438,751 | $360,278 |
| Cost of sales | 129,087 | 118,367 | 256,086 | 218,758 |
| Gross profit | 92,233 | 71,447 | 182,665 | 141,520 |
| Selling, general, and administrative expenses | 55,605 | 45,664 | 109,974 | 88,712 |
| Restructuring costs | 438 | 920 | 6,436 | 2,006 |
| Acquisition related costs | 617 | 16,400 | 1,049 | 18,240 |
| Total operating expenses | 56,660 | 62,984 | 117,459 | 108,958 |
| Income from operations | 35,573 | 8,463 | 65,206 | 32,562 |
| Interest expense | 7,914 | 5,575 | 16,826 | 6,552 |
| Other non-operating expense, net | 490 | 890 | 225 | 862 |
| Income from continuing operations before income taxes | 27,169 | 1,998 | 48,155 | 25,148 |
| Provision for income taxes | 6,536 | 710 | 11,701 | 5,672 |
| Income from continuing operations | 20,633 | 1,288 | 36,454 | 19,476 |
| Income (Loss) from discontinued operations, net of tax | 48 | (13) | 21 | (4) |
| Net income | 20,681 | 1,275 | 36,475 | 19,472 |
| Less: net income attributable to redeemable noncontrolling interest | 18,561 | 418 | 19,300 | 418 |
| Net income attributable to common stockholders | 2,120 | 857 | 17,175 | 19,054 |
| Basic earnings per share attributable to Standex International Corporation shareholders: | ||||
| Continuing operations | 0.17 | 0.07 | 1.43 | $1.60 |
| Discontinued operations | 0.00 | - | 0.00 | - |
| Total | 0.17 | $0.07 | $1.43 | $1.60 |
| Diluted earnings per share attributable to Standex International Corporation shareholders: | ||||
| Continuing operations | 0.17 | 0.07 | 1.42 | $1.59 |
| Discontinued operations | 0.00 | - | 0.00 | - |
| Total | 0.17 | $0.07 | $1.42 | $1.59 |
| Weighted average number of shares: | ||||
| Basic | 12,043 | 11,942 | 12,027 | 11,872 |
| Diluted | 12,055 | 12,025 | 12,073 | 11,972 |
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)
| Three Months Ended December 31, | Six Months Ended December 31, | |||
|---|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2025 | 2024 |
| Net income | $20,681 | $1,275 | $36,475 | $19,472 |
| Other comprehensive income (loss): | ||||
| Defined benefit pension plans: | ||||
| Actuarial (losses) gains and other changes in unrecognized costs, net of tax | (22) | 266 | $57 | $48 |
| Amortization of unrecognized costs, net of tax | 898 | 798 | 1,797 | 1,597 |
| Derivative instruments: | ||||
| Change in unrealized gains (losses), net of tax | 195 | 137 | (588) | (154) |
| Amortization of unrealized losses into interest expense, net of tax | (227) | (1,101) | (346) | (2,385) |
| Foreign currency translation losses, net of tax | (10,004) | (27,447) | (25,278) | (4,436) |
| Other comprehensive loss | (9,160) | (27,347) | (24,358) | (5,330) |
| Total comprehensive income (loss) | 11,521 | (26,072) | 12,117 | 14,142 |
| Less: comprehensive income (loss) attributable to redeemable noncontrolling interest | 18,235 | (99) | 18,196 | (99) |
| Total comprehensive income (loss) attributable to Standex International Corporation | $(6,714) | $(25,973) | $(6,079) | $14,241 |
Unaudited Condensed Consolidated Statements of Stockholders' Equity
| For the three month period ended · Redeemable · Additional · Accumulated Other · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| December 31, 2025 · Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders' | ||||||||
| (in thousands, except as specified) | Interest | Stock | Capital | Earnings | Income (Loss) | Shares | Amount | Equity |
| Balance, September 30, 2025 | $27,149 | $41,976 | $137,415 | $1,138,071 | $(179,185) | 15,951 | $(430,618) | $707,659 |
| Stock issued under incentive compensation plans and employee purchase plans and business acquisitions | - | - | (4) | - | - | (14) | 391 | 387 |
| Stock-based compensation | - | - | 3,065 | - | - | - | - | 3,065 |
| Treasury stock acquired | - | - | - | - | - | - | (66) | (66) |
| Comprehensive income: | - | - | - | - | - | - | - | - |
| Net income | 18,561 | - | - | 2,120 | - | - | - | 2,120 |
| Foreign currency translation adjustment | (326) | - | - | - | (9,678) | - | - | (9,678) |
| Pension, net of tax of $0.3 million | - | - | - | - | 876 | - | - | 876 |
| Change in fair value of derivatives, net of tax of $0.0 million | - | - | - | - | (32) | - | - | (32) |
| Distributions to noncontrolling interests | (873) | - | - | - | - | - | - | - |
| Dividends declared ($0.34 per share) | - | - | - | (4,095) | - | - | - | (4,095) |
| Balance, December 31, 2025 | $44,511 | $41,976 | $140,476 | $1,136,096 | $(188,019) | 15,937 | $(430,293) | $700,236 |
| For the three month period ended December 31, 2024 · Redeemable · Additional · Accumulated Other · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders' | |||||||||
| (in thousands, except as specified) · Interest · Stock · Capital · Earnings · Income (Loss) · Shares · Amount · Equity | |||||||||
| Balance, September 30, 2024 | $ | - | $41,976 | $108,383 | $1,100,924 | $(160,939) | 16,171 | $(432,323) | $658,021 |
| Stock issued under incentive compensation plans and employee purchase plans | - | - | (525) | - | - | (25) | 679 | 154 | |
| Stock issued for business acquisition | 21,882 | - | - | (152) | 4,071 | 25,953 | |||
| Fair value of noncontrolling interest at acquisition | 26,734 | - | - | - | |||||
| Stock-based compensation | - | - | 2,587 | - | - | - | - | 2,587 | |
| Treasury stock acquired | - | - | - | 4 | (784) | (784) | |||
| Comprehensive income: | |||||||||
| Net income | 418 | - | - | 857 | - | - | - | 857 | |
| Foreign currency translation adjustment | (517) | - | - | - | (26,930) | - | - | (26,930) | |
| Pension, net of tax of $0.3 million | - | - | - | - | 1,064 | - | - | 1,064 | |
| Change in fair value of derivatives, net of tax of $0.3 million | - | - | - | - | (964) | - | - | (964) | |
| Dividends declared ($0.32 per share) | - | - | - | (3,924) | - | - | - | (3,924) | |
| Balance, December 31, 2024 | $26,635 | $41,976 | $132,327 | $1,097,857 | $(187,769) | 15,998 | $(428,357) | $656,034 | |
Unaudited Condensed Consolidated Statements of Stockholders' Equity
| For the six month period ended · Redeemable · Additional · Accumulated Other · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| December 31, 2025 · Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders' | ||||||||
| (in thousands, except as specified) | Interest | Stock | Capital | Earnings | Income (Loss) | Shares | Amount | Equity |
| Balance, June 30, 2025 | $27,913 | $41,976 | $136,082 | $1,126,851 | $(164,765) | 15,992 | $(428,467) | $711,677 |
| Stock issued under incentive compensation plans and employee purchase plans | - | - | (444) | - | - | (73) | 1,972 | 1,528 |
| Stock-based compensation | - | - | 4,838 | - | - | - | - | 4,838 |
| Treasury stock acquired | - | - | - | - | - | 18 | (3,798) | (3,798) |
| Comprehensive income: | - | - | - | - | - | |||
| Net Income | 19,300 | - | - | 17,175 | - | - | - | 17,175 |
| Foreign currency translation adjustment | (1,104) | - | - | - | (24,174) | - | - | (24,174) |
| Pension, net of tax of $0.6 million | - | - | - | - | 1,854 | - | - | 1,854 |
| Change in fair value of derivatives, net of tax of $0.3 million | - | - | - | - | (934) | - | - | (934) |
| Distributions to noncontrolling interests | (1,598) | - | - | - | - | - | - | - |
| Dividends declared ($0.66 per share) | - | - | - | (7,930) | - | - | - | (7,930) |
| Balance, December 31, 2025 | $44,511 | $41,976 | $140,476 | $1,136,096 | $(188,019) | 15,937 | $(430,293) | $700,236 |
| For the six month period ended December 31, 2024 · Redeemable · Additional · Accumulated Other · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders' | |||||||||
| (in thousands, except as specified) · Interest · Stock · Capital · Earnings · Income (Loss) · Shares · Amount · Equity | |||||||||
| Balance, June 30, 2024 | $ | - | $41,976 | $106,193 | $1,086,277 | $(182,956) | 16,222 | $(429,987) | $621,503 |
| Stock issued under incentive compensation plans and employee purchase plans | - | - | (903) | - | - | (101) | 2,693 | 1,790 | |
| Stock issued for business acquisition | - | - | 21,882 | - | - | (152) | 4,071 | 25,953 | |
| Fair value of noncontrolling interest at acquisition | 26,734 | - | - | - | - | - | - | - | |
| Stock-based compensation | - | - | 5,155 | - | - | - | - | 5,155 | |
| Treasury stock acquired | - | - | - | - | - | 29 | (5,134) | (5,134) | |
| Comprehensive income: | |||||||||
| Net income | 418 | - | - | 19,054 | - | - | - | 19,054 | |
| Foreign currency translation adjustment | (517) | - | - | - | (3,919) | - | - | (3,919) | |
| Pension, net of tax of $0.5 million | - | - | - | - | 1,645 | - | - | 1,645 | |
| Change in fair value of derivatives, net of tax of $0.8 million | - | - | - | - | (2,539) | - | - | (2,539) | |
| Dividends declared ($0.62 per share) | - | - | - | (7,474) | - | - | - | (7,474) | |
| Balance, December 31, 2024 | $26,635 | $41,976 | $132,327 | $1,097,857 | $(187,769) | 15,998 | $(428,357) | $656,034 | |
** Unaudited Condensed Consolidated Statements of Cash Flows**
| Six Months Ended December 31, | |||
|---|---|---|---|
| (In thousands) · 2025 · 2024 | |||
| Cash flows from operating activities | |||
| Net income | $36,475 | $19,472 | |
| Income (loss) from discontinued operations | 21 | (4) | |
| Income from continuing operations | 36,454 | 19,476 | |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 19,801 | 15,566 | |
| Stock-based compensation | 4,838 | 5,155 | |
| Non-cash portion of restructuring charge | 149 | (896) | |
| Contributions to defined benefit plans | (2,796) | (4,766) | |
| Changes in operating assets and liabilities, net | (20,935) | (7,873) | |
| Net cash provided by operating activities - continuing operations | 37,511 | 26,662 | |
| Net cash used in operating activities - discontinued operations | (127) | (31) | |
| Net cash provided by operating activities | 37,384 | 26,631 | |
| Cash flows from investing activities | |||
| Expenditures for property, plant, and equipment | (14,084) | (13,690) | |
| Expenditures for acquisitions, net of cash acquired | - | (419,652) | |
| Other investing activity | (5) | 3,904 | |
| Net cash used in investing activities | (14,089) | (429,438) | |
| Cash flows from financing activities | |||
| Proceeds from borrowings | 8,000 | 724,313 | |
| Payments of debt | (26,000) | (339,110) | |
| Contingent consideration payment | (330) | - | |
| Activity under share-based payment plans | 1,528 | 1,792 | |
| Purchases of treasury stock and other | (3,798) | (9,582) | |
| Distributions to non-controlling interests | (1,598) | - | |
| Cash dividends paid | (7,930) | (7,362) | |
| Net cash (used in) provided by financing activities | (30,128) | 370,051 | |
| Effect of exchange rate changes on cash and cash equivalents | (711) | (300) | |
| Net change in cash and cash equivalents | (7,544) | (33,056) | |
| Cash and cash equivalents at beginning of year | 104,542 | 154,203 | |
| Cash and cash equivalents at end of period | $96,998 | $121,147 | |
| Supplemental Disclosure of Cash Flow Information: | |||
| Cash paid during the period for: | |||
| Interest | $16,627 | $3,555 | |
| Income taxes, net of refunds | $15,946 | $6,245 | |
| Stock issued for business acquisition | $ | - | $25,953 |
S****TANDEX INTERNATIONAL CORPORATION
Notes to Unaudited** **Condensed Consolidated Financial Statements
1) Management Statement
Standex International Corporation (“Standex” or the “Company”) is a diversified industrial manufacturer infive broad business segments: Electronics, Engineering Technologies, Scientific, Engraving and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. The accompanying consolidated financial statements include the accounts of Standex International Corporation and its subsidiaries and are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany accounts and transactions have been eliminated in consolidation. Noncontrolling interests in subsidiaries related to Standex’ ownership interests of less than100% are reported as Noncontrolling interests in the consolidated balance sheets. The results of noncontrolling ownership interests held by Standex are reported as Net income attributable to redeemable noncontrolling interests in the consolidated statements of operations.
The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated subsequent events through the date and time our consolidated financial statements were issued.
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the results of operations for thethree andsix months ended* December 31, 2025and2024*, the cash flows for thesix months ended* December 31, 2025and2024* and the financial position of Standex International Corporation (“Standex”, the “Company”, “we”, “us”, or “our”), at* December 31, 2025*. The interim results arenot necessarily indicative of results for a full year. The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the informationnot misleading. The unaudited condensed consolidated financial statements and notes donot contain information which would substantially duplicate the disclosures contained in the audited annual consolidated financial statements and notes for the year ended* June 30, 2025*. The condensed consolidated balance sheet at* June 30, 2025* presented herein was derived from audited financial statements, but doesnot include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements contained herein should be read in conjunction with the Annual Report on Form10-K and in particular the audited consolidated financial statements for the year ended* June 30, 2025*. Unless otherwise noted, references to years are to the Company’s fiscal years. Currently the fiscal year end is* June 30.For further clarity, the Company's fiscal year2026* includes thetwelve-month period from* July 1, 2025to June 30, 2026.*
The preparation of consolidated financial statements in conformity with GAAP requires the use of estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the financial statements and for the period then ended. Estimates are based on historical experience, actuarial estimates, current conditions and various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when they arenot readily apparent from other sources. These estimates assist in the identification and assessment of the accounting treatment necessary with respect to commitments and contingencies. Actual results* maydiffer from these estimates under different assumptions or conditions. The estimates and assumptions used in the preparation of the consolidated financial statements have considered the implications on the Company as a result of ongoing global events and related economic impacts. As a result, there is heightened volatility and uncertainty around tariff actions, supply chain performance, labor availability, and customer demand. However, the magnitude of such impact on the Company’s business and its duration is uncertain. The Company isnot* aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of* December 31, 2025* and the issuance date of the quarterly report on Form10-Q.
Research and development expenditures are expensed as incurred. Total research and development costs, which are classified under selling, general, and administrative expenses were $6.3 million and $5.3 million for thethree months ended* December 31, 2025* and2024, respectively. Total research and development costs were $12.5 million and $10.2 million for thesix months ended* December 31, 2025* and2024, respectively.
Recently Issued Accounting Pronouncements
The Organization for Economic Co-operation and Development (OECD) and theG20 Inclusive Framework on Base Erosion and Profit Shifting (the "Inclusive Framework") have put forth Pillar Two proposals that ensure a minimal level of taxation. Several countries in which the Company operates, including several European Union member states, have adopted domestic legislation to implement the Inclusive Framework's global corporate minimum tax rate offifteen percent. This legislation became effective for the Company beginning in the fiscal year2025. Based on the Company's analysis of Pillar Two provisions, these tax law changes didnot have a material impact on the Company's financial statements for the fiscal year2026.
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed below, the Company doesnot believe that the adoption of recently issued standards had or* may*have a material impact on its unaudited condensed consolidated financial statements or disclosures.
9
In* December 2023,the FASB issued ASU2023*-09, Income Taxes (Topic740) - Improvements to Income Tax Disclosures. This ASU is expected to enhance the transparency and decision usefulness of income tax disclosures by requiring public business entities on an annual basis to disclose specific categories in the rate reconciliation, additional information for reconciling items that meet a quantitative threshold, and certain information about income taxes paid. This ASU is effective for fiscal years beginning after* December 15, 2024.The amendments in this ASU are required to be applied on a prospective basis and retrospective adoption is permitted. Based on the Company's current analysis, the Company doesnot* expect these changes to have a material impact on the Company's financial statements.
In* November 2024,the FASB issued ASU2024*-03, Income Statement - Reporting Comprehensive Income (Topic220): Expense Disaggregation Disclosures. Additionally, in* January 2025,the FASB issued ASU2025*-01 to clarify the effective date of ASU2024-03. This ASU provides guidance to expand disclosures related to the disaggregation of income statement expenses. This ASU also requires, in the notes to the financial statements, disclosure of specified information about certain costs and expenses which includes purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. ASU2025-01 is effective for fiscal years beginning after* December 15, 2026,and interim periods within annual reporting periods beginning after December 15, 2027,on a retrospective or prospective basis, with early adoption permitted. This ASU will be effective for the Company’s Form10*-K for fiscal2028 and Form10-Q filed thereafter. The Company is currently evaluating the impact this ASU* may*have on its financial statement disclosures.
In* July 2025,the U.S. government enacted The One Big Beautiful Bill Act of2025* which includes, among other provisions, changes to the U.S. corporate income tax system including the allowance of immediate expensing of qualifying research and development expenses and permanent extensions of certain provisions within the Tax Cuts and Jobs Act. Certain provisions were effective for Standex beginning* June 1, 2025.Based on the Company's current analysis of the provisions, the Company doesnot* expect these tax law changes to have a material impact on the Company's financial statements. The Company will continue to evaluate the impact of these provisions throughout the remainder of the year.
In* July 2025,the FASB issued ASU2025*-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for measuring expected credit losses on current trade receivables and contract assets by assuming that current conditions remain unchanged over the life of the asset. The amendments are effective for annual and interim periods beginning after* December 15, 2025,*with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.
In* September 2025,the FASB issued ASU2025*-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic350-40): Targeted Improvements to the Accounting for Internal-Use Software related to accounting for internal-use software costs. The amendments in this update improve the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. This update is effective for annual periods beginning after* December 15, 2027,*including interim periods within those fiscal years, though early adoption is permitted. The Company is currently in the process of evaluating the effects of this pronouncement on its consolidated financial statements.
In* November 2025,the FASB issued ASU2025*-09, Derivatives and Hedging (Topic815): Hedge Accounting Improvements. This ASU introducesfive targeted improvements to better align hedge accounting with entities’ risk management activities. This ASU is effective for fiscal years beginning after* December 15, 2026,and interim periods within those annual reporting periods, with early adoption permitted. The amendments in this ASU are required to be applied on a prospective basis for all hedging relationships. The Company is currently evaluating the impact this ASU may*have on its financial statement disclosures.
2) Acquisitions
McStarlite
On* February 5, 2025,*the Company acquired 100% of the issued and outstanding shares of Basmat Inc., dba McStarlite, a privately held company, for $57.0 million, net of cash acquired. McStarlite is a leading provider of complex sheet metal aerospace components. It designs and manufactures cold deep draw and bulge-formed aviation components, including segmented and single piece lipskins, nozzles, complex sheet metal assemblies, and tooling to support production hardware. McStarlite's results are reported within the Company's Engineering Technologies segment.
The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to McStarlite's technical and applications expertise, which is highly complementary to the Company's existing business.
Identifiable intangible assets of $24.5 million consist primarily of $19.7 million for customer relationships to be amortized over 12 years and $4.8 million for indefinite lived tradenames. The goodwill of $16.2 million created by the transaction isnot deductible for income tax purposes. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques.
10
During thesix months ended* December 31, 2025*, the Company made the following changes to the purchase price allocation of McStarlite as mentioned below (in thousands):
| Preliminary Allocation as of June 30, 2025 · Adjustments · Preliminary Allocation as of December 31, 2025 | ||||
|---|---|---|---|---|
| Total purchase consideration: | ||||
| Cash payments | $57,549 | $ | - | $57,549 |
| Less: cash acquired | (586) | - | (586) | |
| Total | $56,963 | $ | - | $56,963 |
| Identifiable assets acquired and liabilities assumed: | ||||
| Other acquired assets | $8,808 | $ | - | $8,808 |
| Inventories | 6,744 | - | 6,744 | |
| Customer backlog | 3,970 | - | 3,970 | |
| Property, plant, and equipment | 8,603 | - | 8,603 | |
| Identifiable intangible assets | 24,500 | - | 24,500 | |
| Goodwill | 16,761 | (554) | 16,207 | |
| Liabilities assumed | (12,423) | 554 | (11,869) | |
| Total | $56,963 | $ | - | $56,963 |
There wereno changes to the purchase price allocations of any other acquisitions during thesix months ended* December 31, 2025*.
Amran/Narayan Group
On* October 28, 2024 (*“Closing Date”), the Company acquired, in separate transactions,100% of the outstanding membership interest in Amran LLC (“Amran”), a privately-held company based in Houston, Texas, pursuant to a Securities Purchase Agreement (the “Amran Purchase Agreement”) and through its wholly owned subsidiary, Mold-Tech Singapore PTE LTD (“Mold-Tech Singapore”),90.1% of the capital stock of Narayan Powertech Private Limited (“Narayan”), a privately-held India-based company, pursuant to a Securities Purchase Agreement (the “Narayan Purchase Agreement”) (collectively the “Amran/Narayan Group”). With manufacturing locations in the United States and India, Amran/Narayan Group is a leading manufacturer of low voltage and medium voltage instrument transformers. Its custom product portfolio is specifically designed and developed in partnership with OEMs for their specific equipment related to electrical grid applications. This acquisition continues the Company's portfolio strategy of focusing its higher-margin business segments in faster-growing markets. Amran/Narayan Group results are reported within the Company's Electronics segment.
Total consideration for Amran aggregated $179.7 million consisting of $153.7 million in cash consideration and 152,299 shares of Standex common stock, issued out of the Company's treasury shares, with a fair value of $26.0 million. The fair value of Standex common stock issued as part of the consideration for Amran was determined on the basis of the closing market price of our common shares on the Closing Date. The total consideration for the 90.1% interest in Narayan consisted of a cash payment of $261.9 million. The Company entered into a Shareholder Agreement that provides the Company with the right to purchase, and the noncontrolling interest holders with the right to sell, their remaining minority interest at a contractually defined redemption value. As the redemptions are contingently redeemable at the option of the noncontrolling interest shareholders, the Company classifies the redeemable noncontrolling interest in the mezzanine equity section on the consolidated balance sheets, which is presented above the equity section and below liabilities. The repurchase price of the redeemable noncontrolling interests is the greater of the share price paid for similar shares as part of the Amran/Narayan Acquisition or12 timestwelve months' trailing EBITDA. The redeemable noncontrolling interest represents the minority shareholder's interest. Subject to receipt of regulatory approval from the Reserve Bank of India (“RBI”), Mold-Tech Singapore will acquire the remaining 9.9% of the capital stock of Narayan in asecond closing for shares of Standex common stock with a fair value of $26.7 million ("Share Swap Provision").
Additionally, on* October 28, 2024,as contemplated by the Narayan Purchase Agreement, the Company, Mold-Tech Singapore and the owners of the remaining 9.9% ownership interest in Narayan, which wasnot* acquired by the Company, entered into a Shareholders’ Agreement. The Shareholders’ Agreement provides the noncontrolling interest holders with certain put rights upon the expiration of the Share Swap Provision. The noncontrolling interest holders will have the right (butnot an obligation) to transfer up to their remaining interest in Narayan for a period ofthree years ("Put Option Period") to Mold-Tech Singapore. Subsequent to the expiration of the Put Option Period, Mold-Tech Singapore will have the right (butnot an obligation) to acquire the remaining interest in Narayan for an additional three year consecutive period.
The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed and noncontrolling interest based on a valuation of their fair values on the Closing Date. Goodwill recorded from this transaction is attributable to Amran/Narayan Group’s technical and applications expertise, which is highly complementary to the Company's existing business.
Identifiable intangible assets of $136.0 million consist primarily of $28.7 million for indefinite lived tradenames and $107.3 million of customer relationships to be amortized over 12 years. Goodwill of $298.4 was recognized. Goodwill related to the Amran (U.S.) acquisition is deductible for U.S. income tax purposes; the goodwill related to the Narayan (India) acquisition isnot deductible. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. The fair value of the noncontrolling interest in Narayan was determined based on the consideration expected to be transferred by the Company for its controlling ownership interest based on the Standex share price at the Closing Date.
11
The following table summarizes the allocation of the aggregate total consideration for the Amran/Narayan Group to the estimated fair values of the tangible and identifiable intangible assets acquired and liabilities and noncontrolling interest assumed (in thousands):
| Fair value of business combination: | |
|---|---|
| Total cash consideration | $415,604 |
| Less: cash acquired | (7,114) |
| Stock consideration | 25,953 |
| Total | $434,443 |
| Identifiable assets acquired and liabilities assumed: | |
| Other acquired assets | $11,799 |
| Accounts receivable | 25,863 |
| Inventories | 13,677 |
| Customer backlog | 10,100 |
| Property, plant, and equipment | 2,816 |
| Identifiable intangible assets | 136,000 |
| Goodwill | 298,383 |
| Deferred tax liabilities, net | (19,990) |
| Other liabilities assumed | (17,471) |
| Total identifiable assets acquired and liabilities assumed | 461,177 |
| Redeemable noncontrolling interest (see Note 18) | (26,734) |
| Total identifiable assets, liabilities and redeemable noncontrolling interest | $434,443 |
The following table reflects the unaudited pro forma operating results of the Company for thethree andsix months ended* December 31, 2024,which give effect to the acquisition of the Amran/Narayan Group as if it had occurred effective July 1, 2023.The pro forma results arenot* necessarily indicative of the operating results that would have occurred had the acquisition been effective as of the date indicated, nor are they intended to be indicative of results that* mayoccur in the future. The pro forma information doesnot* include the effects of any synergies related to the Amran/Narayan Group acquisition, transactions between the entities prior to acquisition, or the pre-acquisition impact of other businesses acquired by the Company during this period as they werenot material to the Company’s historical results of operations.
| Three Months Ended | Six Months Ended | |
|---|---|---|
| (in thousands) | December 31, 2024 | |
| Net sales | $199,035 | $396,721 |
| Net income | 16,220 | 43,943 |
Pro forma earnings during the periods presented were adjusted to include the following adjustments:
| ● | Amortization of inventory step-up to fair value assuming inventory turns within a two-month period; |
| ● | Amortization of definite-lived intangible assets recognized at fair value that exceed one year as if acquired July 1, 2023; |
| ● | Non-recurring acquisition-related costs have been excluded from net income; |
| ● | Interest expense (including amortization of loan discount) on the Term Loan Credit Agreement entered into in connection with the acquisition as if the loan was obtained July 1, 2023. The interest rate assumed for purposes of the pro forma financial information was 7.7% on average as the rate in agreement is a variable rate plus certain margins; and |
| ● | Income tax expense (benefit) was adjusted related to the above pro forma adjustments using an estimated tax rate of 22.6%. |
12
With respect to each of the McStarlite and Amran/Narayan Group acquisitions, the estimated fair values of the indefinite lived tradenames were determined based on an income approach using the relief from royalty method, which assumes that, in lieu of ownership, athird party would be willing to pay a royalty in order to exploit the related benefits of the tradenames assets. The cash flow projections the Company uses to estimate the fair value of the tradenames intangible assets involve several assumptions, including projected revenue growth, an estimated royalty rate, after-tax royalty savings expected from ownership of the tradenames, and a discount rate used to derive the estimated fair value of the tradenames. The estimated fair value of the customer relationships intangible assets were determined based on the income approach using the multi-period excess earnings method, which measures the economic benefit indirectly by calculating the income attributable to an asset after appropriate returns are paid to complementary assets used in conjunction with the subject asset to produce the earnings associated with the subject asset, commonly referred to as contributory asset charges. The fair value determination of the customer relationships intangible asset required the Company to make significant estimates and assumptions related to future cash flows and the selection of an appropriate discount rate to apply to future cash flows.
Acquisition Related Costs
Acquisition related costs include costs related to acquired businesses and other pending acquisitions. These costs consist of (i) deferred compensation arrangements and (ii) acquisition related professional service fees and expenses, including financial advisory, legal, accounting, and other outside services incurred in connection with integration and acquisition activities, and regulatory matters related to acquired entities. These costs donot include purchase accounting expenses, which the Company defines as acquired backlog and the step-up of inventory to fair value, or the amortization of the acquired intangible assets.
Acquisition related costs for thethree months ended* December 31, 2025* and2024 were $0.6 million and $16.4 million, respectively. Acquisition related costs for thesix months ended* December 31, 2025and2024* were $1.0 million and $18.2 million, respectively.
3) Revenue From Contracts With Customers
Most of the Company’s contracts have a single performance obligation which represents the product or service being sold to the customer. Some contracts include multiple performance obligations such as a product and the related installation and/or extended warranty. Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications. Assurance type warranties donot represent a separate performance obligation.
In general, the Company recognizes revenue at the point in time control transfers to its customer based on predetermined shipping terms. Revenue is recognized over time under certain long-term contracts within the Engineering Technologies and Engraving segments for highly customized customer products that haveno alternative use and in which the contract specifies the Company has a right to payment for its costs, plus a reasonable margin. For these products, the transfer of control is measured pro rata, based upon current estimates of costs to complete such contracts. Losses on contracts are fully recognized in the period in which the losses become determinable. Revisions in profit estimates are reflected on a cumulative basis in the period in which the basis for such revision becomes known.
Disaggregation of Revenue from Contracts with Customers
The following table presents revenue from continuing operations disaggregated by product line and segment (in thousands):
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| Revenue by Product Line | December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 |
| Electronics | $115,668 | $95,923 | $226,220 | $173,656 |
| Engineering Technologies | 30,636 | 22,649 | 60,530 | 43,179 |
| Scientific | 19,502 | 18,477 | 38,952 | 36,170 |
| Engraving Services | 32,990 | 28,844 | 65,611 | 58,664 |
| Engraving Products | 2,738 | 2,610 | 5,957 | 6,153 |
| Total Engraving | 35,728 | 31,454 | 71,568 | 64,817 |
| Hydraulics Cylinders and Systems | 11,393 | 12,067 | 23,566 | 23,689 |
| Merchandising & Display | 8,393 | 9,244 | 17,915 | 18,767 |
| Total Specialty Solutions | 19,786 | 21,311 | 41,481 | 42,456 |
| Total revenue by product line | $221,320 | $189,814 | $438,751 | $360,278 |
The following table presents revenue from continuing operations disaggregated by geography based on the Company’s locations (in thousands):
| Three Months Ended | Three Months Ended | Six Months Ended | Six Months Ended | |
|---|---|---|---|---|
| Net sales | December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 |
| United States | $128,646 | $111,532 | $254,976 | $212,268 |
| Asia Pacific | 58,338 | 49,706 | 114,721 | 87,401 |
| EMEA (1) | 32,033 | 26,368 | 64,667 | 55,638 |
| Other Americas | 2,303 | 2,208 | 4,387 | 4,971 |
| Total | $221,320 | $189,814 | $438,751 | $360,278 |
(1) EMEA consists primarily of Europe, Middle East and S. Africa.
13
The following table presents revenue from continuing operations disaggregated by timing of recognition (in thousands):
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| Timing of Revenue Recognition | December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 |
| Products and services transferred at a point in time | $200,084 | $169,034 | $397,064 | $321,721 |
| Products transferred over time | 21,236 | 20,780 | 41,687 | 38,557 |
| Net sales | $221,320 | $189,814 | $438,751 | $360,278 |
Contract Balances
Contract assets represent revenue recognized related to work completed butnot yet billed as of the reporting date. Contract liabilities are customer deposits for which revenue hasnot been recognized. Current contract liabilities are recorded as accrued liabilities.
The timing of revenue recognition, invoicing and cash collections results in billed receivables, contract assets and contract liabilities on the consolidated balance sheets. When consideration is received from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue after control of the goods and services are transferred to the customer and all revenue recognition criteria have been met.
The following table provides information about contract assets and liability balances (in thousands):
| June 30, 2025 | Additions | Deductions | December 31, 2025 | |
|---|---|---|---|---|
| Contract assets | $59,228 | $41,687 | $38,041 | $62,874 |
| Contract liabilities: | ||||
| Customer deposits | 5,189 | 7,745 | 2,214 | 10,720 |
| June 30, 2024 | Additions | Deductions | December 31, 2024 | |
|---|---|---|---|---|
| Contract assets | $45,393 | $36,004 | $25,798 | $55,599 |
| Contract liabilities: | ||||
| Customer deposits | 1,766 | 1,805 | 2,377 | 1,194 |
We recognized the following revenue which was included in the contract liability beginning balances (in thousands):
| Three months ended | |||
|---|---|---|---|
| Revenue recognized in the period from: · December 31, 2025 · December 31, 2024 | |||
| Amounts included in the contract liability balance at the beginning of the period | $768 | $ | - |
| Six months ended | ||
|---|---|---|
| Revenue recognized in the period from: | December 31, 2025 | December 31, 2024 |
| Amounts included in the contract liability balance at the beginning of the period | $768 | $1,766 |
4) Fair Value Measurements
The financial instruments shown below are presented at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs arenot available, valuation models* may*be applied.
14
Assets and liabilities recorded at fair value in the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities and the methodologies used in valuation are as follows:
Level1 – Quoted prices (unadjusted) in active markets for identical assets and liabilities. The Company’s deferred compensation plan assets consist of shares in various mutual funds (investments are participant-directed) which invest in a broad portfolio of debt and equity securities. These assets are valued based on publicly quoted market prices for the funds’ shares as of the balance sheet dates.
Level2 – Inputs, other than quoted prices in an active market, that are observable either directly or indirectly through correlation with market data. For foreign exchange forward contracts and interest rate swaps, the Company values the instruments based on the market price of instruments with similar terms, which are based on spot and forward rates as of the balance sheet dates. The Company has considered the creditworthiness of counterparties in valuing all assets and liabilities.
Level3 – Unobservable inputs based upon the Company’s best estimate of what market participants would use in pricing the asset or liability.
There wereno transfers of assets or liabilities between any levels of the fair value measurement hierarchy at* December 31, 2025* or* June 30, 2025*. The Company’s policy is to recognize transfers between levels as of the date they occur.
Cash and cash equivalents, accounts receivable, accounts payable, and debt are carried at cost, which approximates fair value.
The fair values of financial instruments were as follows (in thousands):
| Total · Level 1 · Level 2 · Level 3 | |||||||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Marketable securities - deferred compensation plan | $5,954 | $5,954 | $ | - | $ | - | |
| Liabilities | |||||||
| Interest rate swaps | $1,689 | $ | - | $1,689 | $ | - | |
| Foreign exchange contracts | 1,223 | - | 1,223 | - | |||
| Contingent consideration (a) | 330 | - | - | 330 | |||
| Total · Level 1 · Level 2 · Level 3 | ||||||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Marketable securities - deferred compensation plan | $4,980 | $4,980 | $ | - | $ | - |
| Debt securities | 3,629 | - | - | 3,629 | ||
| Equity securities | 2,211 | - | - | 2,211 | ||
| Liabilities | ||||||
| Foreign exchange contracts | $68 | - | $68 | $ | - | |
| Contingent consideration (a) | 660 | - | - | 660 | ||
(a) The Company’s financial liabilities based upon Level3 inputs comprise of contingent consideration arrangement relating to its acquisition of SEPL in the event that certain financial targets are achieved during thetwo years following its acquisition in thefourth quarter of fiscal year2024. The Company has determined the fair value of the liabilities for the contingent consideration based on an evaluation of the probability and amount of any deferred compensation that has been earned to date. This fair value measurement is based on significant inputsnot observable in the market and thus represents a Level3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are typically the financial performance of the acquired business and the risk-adjusted discount rate for the fair value measurement. During thesix months ended* December 31, 2025*, the reduction in the fair value of the contingent consideration liability was a result of the Company’s payment of $0.3 million pursuant to the SEPL agreement.
The Company invested $2.0 million for equity securities of a company whose securities arenot publicly traded and where fair value isnot readily available. This was recorded as investments within other non-current assets in the consolidated balance sheets to reflect the initial fair value of the stock acquired. These investments are recorded using either the equity method of accounting or the cost minus impairment adjusted for observable price changes, depending on ownership percentage and other factors that suggest significant influence. The Company concluded it doesnot have a significant ownership percentage or influence. The Company monitors these investments to evaluate whether any increase or decline in the value has occurred, based on the implied value of recent company financings, public market prices of comparable companies and general market conditions.
The Company also purchased $2.7 million of debt securities from the same privately held company. The available for sale asset was recorded in the prepaid expenses and other current assets line of the consolidated balance sheet to reflect the initial fair value of the instrument acquired. The maturity date of this asset, which was originally due to matureone year from the date of issuance, has been extended to the end of* February 2026.*
15
The Company updates its assumptions each reporting period based on new developments and records such amounts at fair value based on the revised assumptions.
5) Inventories
Inventories are comprised of the following (in thousands):
| December 31, 2025 | June 30, 2025 | |
|---|---|---|
| Raw materials | $65,922 | $57,302 |
| Work in process | 23,004 | 34,298 |
| Finished goods | 42,270 | 38,394 |
| Total | $131,196 | $129,994 |
Distribution costs associated with the sale of inventory, which are recorded as a component of selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations were $3.2 million and $2.5 million for thethree months ended* December 31, 2025* and2024, respectively. Distribution costs were $6.8 million and $4.9 million for thesix months ended* December 31, 2025and2024*, respectively.
6) Goodwill
Changes to goodwill by reportable segment during the period were as follows (in thousands):
| June 30, 2025 · Acquisitions · Translation Adjustment · December 31, 2025 | |||||
|---|---|---|---|---|---|
| Electronics | $459,051 | $ | - | $(17,014) | $442,037 |
| Engineering Technologies | 53,778 | (554) | (181) | 53,043 | |
| Scientific | 15,454 | - | - | 15,454 | |
| Engraving | 78,996 | - | 1,491 | 80,487 | |
| Specialty Solutions | 3,059 | - | - | 3,059 | |
| Total | $610,338 | $(554) | $(15,704) | $594,080 | |
7) Warranty Reserves
The expected cost associated with warranty obligations on our products is recorded as a component of cost of sales when the revenue is recognized. The Company’s estimate of warranty cost is based on contract terms and historical warranty loss experience that is periodically adjusted for recent actual experience. Since warranty estimates are forecasts based on the best available information, claims costs* may*differ from amounts provided. Adjustments to initial obligations for warranties are made as changes in the obligations become reasonable to estimate.
The change in warranty reserves, which are recorded as a component of accrued liabilities were as follows (in thousands):
| December 31, 2025 | June 30, 2025 | |
|---|---|---|
| Balance at beginning of year | $2,429 | $2,209 |
| Acquisitions and other charges | (48) | 181 |
| Warranty expense | 1,230 | 705 |
| Warranty claims | (707) | (666) |
| Balance at end of period | $2,904 | $2,429 |
**8)**Debt
Long-term debt is comprised of the following (in thousands):
| December 31, 2025 | June 30, 2025 | |
|---|---|---|
| Bank credit agreement | $535,203 | $553,203 |
| Total funded debt | 535,203 | 553,203 |
| Unamortized issuance costs | (470) | (688) |
| Total long-term debt | $534,733 | $552,515 |
16
The Company's bank credit agreement matures in* February**2028.*
At* December 31, 2025*, and* June 30, 2025*, the Company had $3.5 million and $1.9 million standby letters of credit outstanding, primarily for insurance purposes and had the ability to borrow $212.6 million and $207.7 million under the Facility. Funds borrowed under the Facility* maybe used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio, are maintained), and other general corporate purposes. The Facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants which the Company was compliant with as of December 31, 2025* and* June 30, 2025*.
9) Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
| December 31, 2025 | June 30, 2025 | |
|---|---|---|
| Payroll and employee benefits | $20,087 | $24,804 |
| Operating lease current liability | 12,741 | 11,129 |
| Restructuring costs | 2,312 | 1,457 |
| Accrued taxes payable | 3,455 | 2,662 |
| Accrued interest | 3,037 | 3,152 |
| Professional fees | 2,651 | 2,304 |
| Warranty reserves | 2,904 | 2,429 |
| Workers' compensation | 1,710 | 1,245 |
| Contingent consideration | 330 | 330 |
| Other | 20,176 | 13,692 |
| Total | $69,403 | $63,204 |
10)** **Derivative Financial Instruments
Information about the Company’s derivative financial instruments is as follows:
Interest Rate Swaps
From time to time as dictated by market opportunities, the Company enters into interest rate swap agreements designed to manage exposure to interest rates on the Company’s variable rate indebtedness. The Company recognizes all derivatives on its consolidated balance sheets at fair value. The Company designates its interest rate swap agreements, including those that* may*be forward-dated, as cash flow hedges, and changes in the fair value of the swaps are recognized in accumulated other comprehensive income until the hedged items are recognized in earnings. Hedge ineffectiveness, if any, associated with the swaps is reported in earnings within interest expense.
The Company’s effective swap agreements convert the base borrowing rate on $225 million of debt due under our Facility from a variable rate equal to1 month Secured Overnight Financing Rate (SOFR) to a weighted average fixed rate of 3.48% at* December 31, 2025*. The fair value of the swaps, recognized in accumulated other comprehensive loss, is as follows (in thousands, except percentages):
| Effective Date · Notional Amount · Fixed Interest Rate · Maturity · December 31, 2025 · June 30, 2025 | ||||||
|---|---|---|---|---|---|---|
| August 30, 2025 | $225,000 | 3.48% | August 30, 2028 | $(1,223) | $ | - |
The Company reportedno losses for thethree andsix months ended* December 31, 2025*, as a result of hedge ineffectiveness. Future changes in these swap arrangements, including termination of the agreements,* may*result in a reclassification of any gain or loss reported in accumulated other comprehensive loss into earnings as an adjustment to interest expense. Accumulated other comprehensive loss related to these instruments is being amortized into interest expense concurrent with the hedged exposure.
17
Foreign Exchange Contracts
Forward foreign currency exchange contracts are used to limit the impact of currency fluctuations on certain anticipated foreign cash flows, such as collections from customers and loan payments between subsidiaries. The Company enters into such contracts for hedging purposes only. At* December 31, 2025* and* June 30, 2025*, the Company had the following outstanding forward contract related to hedge of intercompany loans. The contract matures in* January 2026.*
The notional amounts of the Company’s forward contracts are as follows (in thousands):
| Currency | December 31, 2025 | June 30, 2025 |
|---|---|---|
| JPY | $3,650,000 | $3,250,000 |
The table below presents the fair value of derivative financial instruments as well as their classification on the balance sheet (in thousands):
| Liability Derivatives | |||||
|---|---|---|---|---|---|
| December 31, 2025 · June 30, 2025 | |||||
| Derivative · Balance Sheet Line Item · Fair Value · Balance Sheet Line Item · Fair Value | |||||
| Interest rate swaps | Accrued liabilities | $1,223 | $ | - | |
| Foreign exchange contracts | Accrued liabilities | 1,689 | Accrued liabilities | 68 | |
| $2,912 | $68 | ||||
The table below presents the amount reclassified from accumulated other comprehensive loss to net income for the periods ended (in thousands):
| Details about Accumulated Other · Three Months Ended · Six Months Ended · Affected line item in the Unaudited | |||||
|---|---|---|---|---|---|
| Comprehensive Loss Components | December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | Condensed Statements of Operations |
| Interest rate swaps | $(298) | $(1,454) | $(453) | $(3,151) | Interest expense |
11) Retirement Benefits
The Company has defined benefit pension plans covering certain current and former employees both inside and outside of the U.S. The Company’s pension plan for U.S. employees is frozen for substantially all participants and has been replaced with a defined contribution benefit plan.
Net periodic benefit cost for the Company’s U.S. and foreign pension benefit plans for the periods ended consisted of the following components (in thousands):
| U.S. Plans · Non-U.S. Plans | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended December 31, · Three Months Ended December 31, | ||||||
| 2025 · 2024 · 2025 · 2024 | ||||||
| Service cost | $ | - | $ | - | $56 | $62 |
| Interest cost | 2,288 | 2,386 | 311 | 302 | ||
| Expected return on plan assets | (2,521) | (2,641) | (300) | (343) | ||
| Recognized net actuarial loss | 1,175 | 1,055 | - | - | ||
| Amortization of prior service cost | - | - | (1) | (1) | ||
| Net periodic (benefit) cost | $942 | $800 | $66 | $20 | ||
| U.S. Plans · Non-U.S. Plans | ||||||
|---|---|---|---|---|---|---|
| Six Months Ended December 31, · Six Months Ended December 31, | ||||||
| 2025 · 2024 · 2025 · 2024 | ||||||
| Service cost | $ | - | $ | - | $114 | $125 |
| Interest cost | 4,577 | 4,772 | 626 | 608 | ||
| Expected return on plan assets | (5,041) | (5,282) | (604) | (690) | ||
| Recognized net actuarial loss | 2,349 | 2,111 | - | - | ||
| Amortization of prior service cost | - | - | (2) | (2) | ||
| Net periodic (benefit) cost | $1,885 | $1,601 | $134 | $41 | ||
18
The following table sets forth the amounts recognized for the Company's defined benefit pension plans (in thousands):
| Amounts recognized in the consolidated balance sheets consist of: | December 31, 2025 | June 30, 2025 |
|---|---|---|
| Prepaid benefit cost | $3,322 | $3,294 |
| Current liabilities | (1,258) | (589) |
| Non-current liabilities | (30,957) | (31,721) |
| Net amount recognized | $(28,893) | $(29,016) |
The contributions made to defined benefit plans are presented below along with remaining contributions to be made for the current fiscal year (in thousands):
| Three Months Ended · Six Months Ended | |||
|---|---|---|---|
| Contributions to defined benefit plans | December 31, 2025 | December 31, 2025 | Remaining Contributions |
| United States, funded plan | $1,483 | $2,742 | $3,807 |
| United States, unfunded plan | 28 | 54 | 62 |
| Germany, unfunded plan | - | - | 275 |
| $1,511 | $2,796 | $4,144 | |
12**) Income Taxes**
The Company's effective tax rate from continuing operations for thethree andsix months ended* December 31, 2025* was 24.1% and 24.3%, respectively, compared with 35.5% and 22.6% for the equivalent prior year periods, respectively.
The tax rate was impacted in thethree andsix months ended* December 31, 2025* by the following items: (i) changes in the geographic mix of earnings; (ii) the recognition of a discrete tax benefit related to equity compensation; (iii) foreign withholding taxes; and (iv) federal tax credits related to research and development activities. The tax rate was impacted in thethree andsix months ended* December 31, 2024* by the following items: (i) a discrete tax benefit related to equity compensation, (ii) a discrete tax expense related to the write-off of foreign deferred tax assets, (iii) the jurisdictional mix of earnings, (iv) foreign withholding taxes; and (v) federal research and development tax credits.
**13)**Earnings Per Share
The Company uses shares acquired through treasury stock repurchases for the issuance of shares of common stock for the settlement of awards under its stock-based compensation plans, with the net effect of these transactions accounting for the change in common stock outstanding.
The following table sets forth a reconciliation of the number of shares (in thousands) used in the computation of basic and diluted earnings per share:
| Three Months Ended December 31, | Six Months Ended December 31, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Basic - Average shares outstanding | 12,043 | 11,942 | 12,027 | 11,872 |
| Dilutive effect of unvested, restricted stock awards | 12 | 83 | 46 | 100 |
| Diluted - Average shares outstanding | 12,055 | 12,025 | 12,073 | 11,972 |
Earnings available to common stockholders are the same for computing both basic and diluted earnings per share. There wereno outstanding instruments that had an anti-dilutive effect at* December 31, 2025* or2024.
Performance stock units of 62,558 and 111,830 for thethree andsix months ended* December 31, 2025* and2024, respectively, are excluded from the diluted earnings per share calculation as the performance criteria havenot been met.
14**)**** Accumulated OtherComprehensiveL****oss**
The components of the Company’s accumulated other comprehensive loss are as follows (in thousands):
| December 31, 2025 | June 30, 2025 | |
|---|---|---|
| Foreign currency translation adjustment | $(98,962) | $(74,788) |
| Unrealized pension losses, net of tax | (89,118) | (90,972) |
| Unrealized gains on derivative instruments, net of tax | 61 | 995 |
| Total | $(188,019) | $(164,765) |
15**) Contingencies**
From time to time, the Company is subject to various claims and legal proceedings, including claims related to environmental remediation, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of these proceedings and claims cannot be predicted with certainty, the Company’s management doesnot believe that the outcome of any of the currently existing legal matters will have a material impact on the Company’s consolidated financial position, results of operations or cash flow. The Company accrues for losses related to a claim or litigation when the Company’s management considers a potential loss probable and can reasonably estimate such potential loss.
19
16) Industry Segment Information
The Company hasfive reportable segments organized around the types of products sold:
| • | Electronics – manufactures and sells electronic components for applications throughout the end user market spectrum; |
| • | Engineering Technologies – provides net and near net formed single-source customized solutions in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets; |
| • | Scientific – sells specialty temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech and industrial markets; |
| • | Engraving - provides mold texturing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery for a number of industries; |
| • | Specialty Solutions – an aggregation of two operating segments that manufacture and sell refrigerated, heated and dry merchandizing display cases and single and double acting telescopic and piston rod hydraulic cylinders. |
Net sales and income from continuing operations by segment were as follows (in thousands):
| Electronics | Engineering Technologies | Scientific | Engraving | Specialty Solutions | Total | |
|---|---|---|---|---|---|---|
| Net Sales | $115,668 | $30,636 | $19,502 | $35,728 | $19,786 | $221,320 |
| Segment Expenses | (85,903) | (26,259) | (15,014) | (29,160) | (17,674) | (174,010) |
| Segment operating income | 29,765 | 4,377 | 4,488 | 6,568 | 2,112 | 47,310 |
| Corporate | (10,682) | |||||
| Restructuring costs | (438) | |||||
| Acquisition related costs | (617) | |||||
| Income From Operations | 35,573 | |||||
| Interest expense | (7,914) | |||||
| Other non-operating expense, net | (490) | |||||
| Income from continuing operations before income taxes | $27,169 | |||||
| Electronics | Engineering Technologies | Scientific | Engraving | Specialty Solutions | Total | |
|---|---|---|---|---|---|---|
| Net Sales | $226,220 | $60,530 | $38,952 | $71,568 | $41,481 | $438,751 |
| Segment Expenses | (168,172) | (52,536) | (29,785) | (58,464) | (36,481) | (345,438) |
| Segment operating income | 58,048 | 7,994 | 9,167 | 13,104 | 5,000 | 93,313 |
| Corporate | (20,622) | |||||
| Restructuring costs | (6,436) | |||||
| Acquisition related costs | (1,049) | |||||
| Income From Operations | 65,206 | |||||
| Interest expense | (16,826) | |||||
| Other non-operating expense income, net | (225) | |||||
| Income from continuing operations before income taxes | $48,155 | |||||
| Electronics | Engineering Technologies | Scientific | Engraving | Specialty Solutions | Total | |
|---|---|---|---|---|---|---|
| Net Sales | $95,923 | $22,649 | $18,477 | $31,454 | $21,311 | $189,814 |
| Segment Expenses | (78,504) | (18,957) | (13,759) | (27,332) | (17,749) | (156,301) |
| Segment operating income | 17,419 | 3,692 | 4,718 | 4,122 | 3,562 | 33,513 |
| Corporate | (7,730) | |||||
| Restructuring costs | (920) | |||||
| Acquisition related costs | (16,400) | |||||
| Income From Operations | 8,463 | |||||
| Interest expense | 5,575 | |||||
| Other non-operating expense, net | 890 | |||||
| Income from continuing operations before income taxes | $1,998 | |||||
20
| Electronics | Engineering Technologies | Scientific | Engraving | Specialty Solutions | Total | |
|---|---|---|---|---|---|---|
| Net Sales | $173,656 | $43,179 | $36,170 | $64,817 | $42,456 | $360,278 |
| Segment Expenses | (139,209) | (35,477) | (26,703) | (54,871) | (35,346) | (291,606) |
| Segment operating income | 34,447 | 7,702 | 9,467 | 9,946 | 7,110 | 68,672 |
| Corporate | (15,864) | |||||
| Restructuring costs | (2,006) | |||||
| Acquisition related costs | (18,240) | |||||
| Income From Operations | 32,562 | |||||
| Interest expense | 6,552 | |||||
| Other non-operating expense, net | 862 | |||||
| Income from continuing operations before income taxes | $25,148 | |||||
Capital expenditures and depreciation and amortization expense by segment were as follows (in thousands):
| Capital Expenditures | Depreciation and Amortization | |||
|---|---|---|---|---|
| Three Months Ended December 31, 2025 | Three Months Ended December 31, 2024 | Three Months Ended December 31, 2025 | Three Months Ended December 31, 2024 | |
| Electronics | $4,079 | $2,248 | $5,806 | $4,957 |
| Engineering Technologies | 761 | 1,429 | 1,549 | 897 |
| Scientific | 180 | 474 | 318 | 311 |
| Engraving | 770 | 1,483 | 1,778 | 1,916 |
| Specialty Solutions | 1,868 | 1,095 | 420 | 363 |
| Corporate and Other | 6 | 236 | 113 | 61 |
| Total | $7,664 | $6,965 | $9,984 | $8,505 |
| Capital Expenditures | Depreciation and Amortization | |||
|---|---|---|---|---|
| Six Months Ended December 31, 2025 | Six Months Ended December 31, 2024 | Six Months Ended December 31, 2025 | Six Months Ended December 31, 2024 | |
| Electronics | $7,747 | $5,799 | $11,591 | $8,371 |
| Engineering Technologies | 2,346 | 2,892 | 2,957 | 1,783 |
| Scientific | 251 | 543 | 638 | 630 |
| Engraving | 1,342 | 2,424 | 3,566 | 3,945 |
| Specialty Solutions | 2,324 | 1,538 | 842 | 714 |
| Corporate and Other | 74 | 494 | 207 | 123 |
| Total | $14,084 | $13,690 | $19,801 | $15,566 |
Net sales include only transactions with unaffiliated customers and includeno intersegment sales. Income from operations by segment excludes interest expense and other non-operating (income) expense.
17) Restructuring
The Company has undertaken a number of initiatives that have resulted in severance, restructuring, and related charges. Related charges* mayincludethird* party assistance with analysis and implementation of these activities.
21
2026 Restructuring Initiatives
The Company continues to focus its efforts to reduce cost and improve productivity across its businesses. Restructuring expenses primarily related to facility rationalizations and consolidations. The Company expects the2026 restructuring activities to be completed by fiscal year2027.
Prior Year Restructuring Initiatives
Restructuring expenses primarily related to headcount reductions and other cost saving initiatives within our Engraving and Electronics segments. The Company expects the prior year restructuring activities to be completed by fiscal year2026.
A summary of charges by initiative is as follows (in thousands):
| Three Months Ended December 31, 2025 | Six Months Ended December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Fiscal Year 2026 | Involuntary Employee Severance and Benefit Costs | Other | Total | Involuntary Employee Severance and Benefit Costs | Other | Total |
| Current year initiatives | $197 | $51 | $248 | $4,798 | $133 | $4,931 |
| Prior year initiatives | 15 | 175 | $190 | 861 | 644 | $1,505 |
| $212 | $226 | $438 | $5,659 | $777 | $6,436 | |
| Three Months Ended December 31, 2024 | Six Months Ended December 31, 2024 | |||||
|---|---|---|---|---|---|---|
| Fiscal Year 2025 | Involuntary Employee Severance and Benefit Costs | Other | Total | Involuntary Employee Severance and Benefit Costs | Other | Total |
| Current year initiatives | $515 | $92 | $607 | $780 | $258 | $1,038 |
| Prior year initiatives | 80 | 233 | 313 | 424 | 544 | 968 |
| $595 | $325 | $920 | $1,204 | $802 | $2,006 | |
Activity in the restructuring liability reserve related to the initiatives is as follows (in thousands):
| Current Year Initiatives | Involuntary Employee Severance and Benefit Costs | Other | Total |
|---|---|---|---|
| Restructuring liabilities at June 30, 2025 · $ · - · $ · - · $ · - | |||
| Additions and adjustments | 4,798 | 133 | 4,931 |
| Payments | (2,881) | - | (2,881) |
| Restructuring liabilities at December 31, 2025 | $1,917 | $133 | $2,050 |
| Prior Year Initiatives · Involuntary Employee Severance and Benefit Costs · Other · Total | ||||
|---|---|---|---|---|
| Restructuring liabilities at June 30, 2025 | $1,397 | $60 | $1,457 | |
| Additions and adjustments | 861 | 644 | 1,505 | |
| Payments | (1,996) | (704) | (2,700) | |
| Restructuring liabilities at December 31, 2025 | $262 | $ | - | $262 |
22
| Prior Year | Involuntary Employee Severance and Benefit Costs | Other | Total |
|---|---|---|---|
| Restructuring liabilities at June 30, 2024 | $1,253 | $194 | $1,447 |
| Additions and adjustments | 423 | 545 | 968 |
| Payments | (1,261) | (603) | (1,864) |
| Restructuring liabilities at December 31, 2024 | $415 | $136 | $551 |
The Company’s total restructuring expenses by segment are as follows:
| Three Months Ended December 31, 2025 · Six Months Ended December 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Involuntary Employee Severance and Benefit Costs · Other · Total · Involuntary Employee Severance and Benefit Costs · Other · Total | |||||||
| Electronics | $ | - | $90 | $90 | $426 | $389 | $815 |
| Engineering Technologies | 19 | - | 19 | 19 | - | 19 | |
| Engraving | 193 | 136 | 329 | 5,143 | 388 | 5,531 | |
| Specialty Solutions | - | - | - | 71 | - | 71 | |
| $212 | $226 | $438 | $5,659 | $777 | $6,436 | ||
| Three Months Ended December 31, 2024 · Six Months Ended December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|
| Involuntary Employee Severance and Benefit Costs · Other · Total · Involuntary Employee Severance and Benefit Costs · Other · Total | |||||||
| Engraving | $498 | $325 | $823 | 1,028 | 802 | 1,830 | |
| Electronics | $97 | $ | - | 97 | 97 | - | 97 |
| Corporate | - | - | - | 79 | - | 79 | |
| $595 | $325 | $920 | $1,204 | $802 | $2,006 | ||
Restructuring expense is expected to be approximately $1.0 million for the remainder of fiscal year2026.
18) Redeemable Noncontrolling Interest
The redeemable noncontrolling interest consists of 9.9% of common stock of Narayan Powertech Private Limited ("Narayan"), a privately-held India-based company. The Company owns the remaining 90.1%. During thethree andsix months ended* December 31, 2025*, Narayan declared and distributed a dividend of $0.9 million and $1.6 million, respectively, to the Company and its noncontrolling interests, allocated according to equity ownership.
In accounting for the subsequent measurement of the redeemable noncontrolling interest measurement adjustments pursuant to ASC480, Distinguishing Liabilities from Equity, the Company has made accounting policy elections to record any such applicable changes on the immediate recognition of the full adjustment required to report the redeemable noncontrolling interest at its redemption value, while also electing to record such adjustments under the income method, with a corresponding offset recorded to the Net income attributable to noncontrolling interests in consolidated subsidiaries within the consolidated statement of operations for the period in which such measurement adjustment becomes required. Given the lack of approval from RBI for thesecond closing and share swap, part of the noncontrolling interest is currently redeemable and the remaining noncontrolling interest is probable of redemption as of* December 31, 2025*. A re-measurement adjustment of $18 million has been recorded for thethree andsix months ended* December 31, 2025* to record the non-controlling interest as of* December 31, 2025*at its estimated redemption value based on the terms of the agreement with the non-controlling interest shareholder. This re-measurement adjustment has been recorded as a component of the total net income attributable to redeemable noncontrolling interest financial statement line in the Company’s condensed consolidated statements of operations.
23
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.